Found: 6
Select item for more details and to access through your institution.
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40235-8
- By:
- Publication type:
- Article
Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 168, n. 2, p. 317, doi. 10.1007/s11060-024-04672-9
- By:
- Publication type:
- Article
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 165, n. 3, p. 467, doi. 10.1007/s11060-023-04500-6
- By:
- Publication type:
- Article
The white matter is a pro-differentiative niche for glioblastoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22225-w
- By:
- Publication type:
- Article
Author Correction: The white matter is a pro-differentiative niche for glioblastoma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Key Pharmacokinetic Parameters of 74 Pediatric Anticancer Drugs Providing Assistance in Preclinical Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 904, doi. 10.1002/cpt.3002
- By:
- Publication type:
- Article